69 results
S-3ASR
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
reimbursement that may be received from payors;
our need for and ability to obtain additional funding, on favorable terms or at all, including as a result … to reimbursement as referred to above for (i) any liability incurred to the registrant or any associated company, (ii) the payment of a fine imposed
10-K
2023 FY
EX-10.12
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
, with respect to a product in any country or other jurisdiction, any approval (including, where required, pricing and reimbursement approvals), registration … such subsequent deduction or reimbursement, any effect resulting from currency conversion is benefit or burden of Receiving Party as taxpayer and not borne
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
, if approved, and the rate and degree of market acceptance of our product candidates, including reimbursement that may be received from payors;
our … . Similar regulations are in place in other jurisdictions.
Coverage, Pricing and Reimbursement
Significant uncertainty exists as to the coverage
424B5
AUTL
Autolus Therapeutics plc
9 Feb 24
Prospectus supplement for primary offering
5:15pm
reimbursement that may be received from payors;
S-9
our need for and ability to obtain additional funding, on favorable terms or at all, including … acceptance of our product candidates, including reimbursement that may be received from payors;
our need for and ability to obtain additional funding
S-3ASR
AUTL
Autolus Therapeutics plc
7 Feb 24
Automatic shelf registration
10:00pm
, and the rate and degree of market acceptance of our product candidates, including reimbursement that may be received from payors;
our need … Act 2006, there shall be no entitlement to reimbursement as referred to above for (i) any liability incurred to the Registrant or any associated
S-3ASR
EX-4.7
ea3npr74 plxm0fy
7 Feb 24
Automatic shelf registration
10:00pm
10-Q
EX-10.1
6rqquy3zchuhhqk30n
9 Nov 23
Quarterly report
4:18pm
10-Q
g7metoz gaj
9 Nov 23
Quarterly report
4:18pm
S-8
ftujow vskppq48
3 Nov 23
Registration of securities for employees
4:02pm
6-K
EX-99.3
znoc74x69yyhy
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
S-8
dtp9mxwg3xdevs0w0jhy
7 Aug 23
Registration of securities for employees
4:57pm
424B5
cac11e
9 Dec 22
Prospectus supplement for primary offering
5:40pm
424B5
mc6bjnibc tgqfid6gjn
8 Dec 22
Prospectus supplement for primary offering
4:10pm
6-K
EX-1
q5y 2z0xq0ep3
1 Jul 22
Current report (foreign)
5:15pm
424B3
lgy2u
18 May 22
Prospectus supplement
4:09pm
F-3
3130prcwofh42f
3 May 22
Shelf registration (foreign)
7:25pm
424B3
nfa6et9j
3 May 22
Prospectus supplement
4:55pm
F-3
dbis1zrtv bw
14 Apr 22
Shelf registration (foreign)
9:30pm